Tal Sella

1.8k citations

66 papers · 1.0k indexed · h-index 18

Impact in

Obstetrics and Gynecology top 5%
- Gestational Diabetes Research and Management
- Pregnancy and preeclampsia studies
Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies

Papers in

Cancer Research 21
- Breast Cancer Treatment Studies 14
Oncology 34
- Cancer Risks and Factors 11
- Cancer Treatment and Pharmacology 8
- Cancer survivorship and care 6
- HER2/EGFR in Cancer Research 4

Co-authors: Varda Shalev Gabriel Chodick Avi Porath Ehud Kokia Anthony Heymann Uriel Elchalal G. Chodick Ann H. Partridge
Journals: Cancer (5 papers)Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (4 papers)Clinical Cancer Research (2 papers)
Partner nations: Israel United States Canada

In The Last Decade

Tal Sella

60 papers receiving 1.0k citations

Peers

Countries citing papers authored by Tal Sella

Since Specialization

Citations

This map shows the geographic impact of Tal Sella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Sella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Sella more than expected).

Fields of papers citing papers by Tal Sella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Sella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Sella. The network helps show where Tal Sella may publish in the future.

Co-authors

The 25 scholars most cited alongside Tal Sella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tal Sella Line = papers co-authored together Tal Sella links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Retrospective, Single-Center Study Comparing Neoadjuvant ACTHP vs. DCbHP in HER2-Positive Early Breast Cancer Patients Cancers ·Patrick Jordy de Lima Barbosa, 中村正久, Keren Levanon, Tal Sella, Rinat Bernstein‐Molho, 郭成正 GUO Cheng-zheng, Осипов Никита Алексеевич, Dana Fourey, Einav Nili Gal‐Yam	2025	0
2	Abstract PO4-01-11: Ovarian function suppression (OFS) use beyond five years?: Young breast cancer patient preferences Cancer Research ·Δημήτριος Ν. Κουρέας, Tal Sella, Z. Khan, Dina Rodríguez, Mohammed Reza Habibzadeh, Patricia A. Spears, Karla V. Ballman, Lisa A. Carey, Ann H. Partridge	2024	0
3	Breastfeeding experiences among young breast cancer survivors: A survey study Cancer ·Tal Sella, Виктория Шабинская, Shoshana M. Rosenberg, Cristian Yáñez, Gregory J. Kirkner, Dina Rodríguez, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann H. Partridge	2024	3
4	Long-term safety of controlled ovarian stimulation for fertility preservation before chemotherapy treatment in patients with breast cancer Fertility and Sterility ·Moran Shapira, Tal Sella, Christos Souliotis, E Villain, Bojana Nevajdić, Raoul Orvieto, Einav Nili Gal‐Yam, Dror Meirow	2024	2
5	Clonal Hematopoiesis in Young Women Treated for Breast Cancer Clinical Cancer Research ·Christopher J. Gibson, Geoffrey Fell, Tal Sella, Adam S. Sperling, Dina Rodríguez, Shoshana M. Rosenberg, Gregory J. Kirkner, CW, Deborah Dillon, Alexander G. Bick, Donna Neuberg, Ann H. Partridge, Peter G. Miller	2023	15
6	Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors Cancer ·Виктория Шабинская, Tal Sella, Shoshana M. Rosenberg, Cristian Yáñez, Gregory J. Kirkner, Dina Rodríguez, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann H. Partridge	2023	2
7	Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors npj Breast Cancer ·Tal Sella, Yue Zheng, Shoshana M. Rosenberg, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Lisa A. Carey, Eric P. Winer, Ann H. Partridge	2023	3
8	Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study Cancer ·Jennifer A. Ligibel, Yue Zheng, William T. Barry, Tal Sella, Kathryn J. Ruddy, Mary L. Greaney, Shoshana M. Rosenberg, Karen M. Emmons, Ann H. Partridge	2023	1
9	Abstract P5-08-06: Breastfeeding in Survivors of Early Breast Cancer Cancer Research ·Tal Sella, Виктория Шабинская, Shoshana M. Rosenberg, 高应俊 GAO Yingjun, Z. Khan, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann Partridge	2023	2
10	Patient perspectives on testing for clonal hematopoiesis of indeterminate potential Blood Advances ·Tal Sella, Geoffrey Fell, Peter G. Miller, Christopher J. Gibson, Shoshana M. Rosenberg, Dina Rodríguez, Daniel G. Stover, Kathryn J. Ruddy, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Elizabeth S. Frank, Donna Neuberg, Benjamin L. Ebert, Ann H. Partridge	2022	8
11	Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors Cancer ·Tal Sella, Yue Zheng, D.K. Lee, Shoshana M. Rosenberg, Philip D. Poorvu, Nabihah Tayob, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Lidia Schapira, Steven E. Come, Jeffrey Peppercorn, Virginia F. Borges, Ann H. Partridge, Jennifer A. Ligibel	2022	10
12	Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT) npj Breast Cancer ·Tal Sella, Yue Zheng, Nabihah Tayob, Kathryn J. Ruddy, Rachel A. Freedman, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Michelle K. DeMeo, Harold J. Burstein, Eric P. Winer, Antonio C. Wolff, Ian E. Krop, Ann H. Partridge, Sara M. Tolaney	2022	5
13	Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer Breast Cancer Research and Treatment ·Shoshana M. Rosenberg, Yue Zheng, Shari Gelber, Kathryn J. Ruddy, Philip D. Poorvu, Tal Sella, Rulla M. Tamimi, Johanna Wassermann, Lidia Schapira, Virginia F. Borges, Steven E. Come, Jeffrey Peppercorn, Karen Sepucha, Ann H. Partridge	2022	6
14	Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma Clinical Cancer Research ·Raquel Nunes, Tal Sella, Kai Treuner, Jennifer M. Atkinson, Georges Kesseng Mayben, Yi Zhang, Pedro Exman, David J. Dabbs, Andrea L. Richardson, Catherine A. Schnabel, Dennis C. Sgroi, Steffi Oesterreich, Ashley Cimino‐Mathews, Otto Metzger	2021	13
15	Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors Cancer ·Tal Sella, Philip D. Poorvu, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ann H. Partridge, Shoshana M. Rosenberg	2021	32
16	ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis Breast Cancer Research ·Adi Zundelevich, Maya Dadiani, I. Selesnev, Patrick Jordy de Lima Barbosa, Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, Nguyen Thi Thu Trieu, Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam	2020	67
17	L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients SHILAP Revista de lepidopterología ·Giovanna Santos, Devorah Schoenfeld, Iris Eshed, A.A Yevtushenko, Tal Sella, A. W. Green, Nina Muirhead, Svetlana Kanashina, Gad Segal	2019	2
18	Adherence and Persistence to Adjuvant Hormonal Therapy in Early-Stage Breast Cancer Patients: A Population-Based Retrospective Cohort Study in Israel Breast Care ·Tal Sella, Gabriel Chodick	2019	14
19	Preferences for disclosure of disease related information among thoracic cancer patients Lung Cancer ·Tal Sella, Alok kumarkasgar, И.Ғ. Икрамов, Haim Biran, Абрамов Лев Викторович, Damien Urban, Amir Onn, Jair Bar	2015	4
20	A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000–2008 Diabetic Medicine ·Tal Sella, A. Dalmatov, E. Gazapo, Varda Shalev, Orit Blumenfeld, Zvi Laron, G. Chodick	2010	32

About Tal Sella

Tal Sella is a scholar working on Cancer Research, Oncology, Family Practice, Geriatrics and Gerontology and Reproductive Medicine, having authored 66 papers that have together received 1.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Risks and Factors (11 papers), Cancer Treatment and Pharmacology (8 papers), Cancer survivorship and care (6 papers), Breast Lesions and Carcinomas (5 papers), Reproductive Biology and Fertility (4 papers), Family Support in Illness (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Obstetrics and Gynecology (149 citations), Cancer Research (224 citations), Oncology (375 citations), Reproductive Medicine (103 citations) and Geriatrics and Gerontology (34 citations). Tal Sella has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Varda Shalev, Gabriel Chodick, Avi Porath, Ehud Kokia, Anthony Heymann, Uriel Elchalal, G. Chodick, Ann H. Partridge, Eitan Lunenfeld and Hanan Guzner‐Gur. Their work appears in journals such as Cancer, Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact